Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.4
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Revenues:      
Total revenues $ 69,056 $ 68,458 $ 60,594
Costs and operating expenses:      
Cost of product revenue 13,742 15,632 12,620
Research and development 44,185 33,873 29,978
Selling, general and administrative 35,049 31,502 29,291
Total costs and operating expenses 92,976 81,007 71,889
Income (loss) from operations (23,920) (12,549) (11,295)
Interest income 405 1,287 671
Other expenses, net (156) (656) (291)
Loss before income taxes (23,671) (11,918) (10,915)
Provision for (benefit from) income taxes 339 17 (37)
Net loss $ (24,010) $ (11,935) $ (10,878)
Net loss per share, basic and diluted (usd per share) $ (0.40) $ (0.21) $ (0.21)
Weighted average common stock shares used in computing net loss per share, basic and diluted (shares) 59,360 56,525 52,205
Product revenue      
Revenues:      
Total revenues $ 30,220 $ 29,465 $ 25,590
Research and development revenue      
Revenues:      
Total revenues $ 38,836 $ 38,993 $ 35,004